Plain-English translation of NCT06903845 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a smartphone app that reminds you to take your medication—combined with video calls from your healthcare team every two weeks—can help you take apixaban more consistently. Apixaban is a blood thinner prescribed to people with atrial fibrillation (irregular heartbeat) who also have other heart conditions. The study wants to see if the combination of reminders and personal support from your doctor works better than the app alone.
Many people with atrial fibrillation struggle to take their blood thinner medication every day as prescribed, which increases their risk of stroke. This trial is testing whether combining a simple reminder app with regular video check-ins from a healthcare provider can help people stick with this important medication.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups. Both groups will use a smartphone app that reminds you to take your medication each day. If you're in the additional support group, you'll also have a video call with a healthcare provider every two weeks to answer questions and encourage you to use the app. The study lasts 8 weeks, and researchers will measure how well you stick to taking your medication by comparing the two groups at the end.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
South Korea